The P2X7 Receptor in Infection and Inflammation

Immunity

Volumn 47, Issue 1, 2017, Pages 15-31

  Di Virgilio, Francesco ^a   Dal Ben, Diego ^b   Sarti, Alba Clara ^a   Giuliani, Anna Lisa ^a   Falzoni, Simonetta ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INFLAMMASOME; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2X RECEPTOR AGONIST;

CELL GROWTH; ENERGY METABOLISM; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; INFECTION; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MALIGNANT NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; T LYMPHOCYTE; ANIMAL; CELL DIFFERENTIATION; IMMUNOLOGY; METABOLISM;

ANIMALS; CELL DIFFERENTIATION; HUMANS; INFECTION; INFLAMMASOMES; INFLAMMATION; MACROPHAGES; PURINERGIC P2X RECEPTOR AGONISTS; RECEPTORS, PURINERGIC P2X7; T-LYMPHOCYTES;

EID: 85030437105     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2017.06.020     Document Type: Review

References (197)

1. Abramowski, P., Ogrodowczyk, C., Martin, R., Pongs, O., A truncation variant of the cation channel P2RX5 is upregulated during T cell activation. PLoS ONE, 9, 2014, e104692.
2. Adinolfi, E., Callegari, M.G., Ferrari, D., Bolognesi, C., Minelli, M., Wieckowski, M.R., Pinton, P., Rizzuto, R., Di Virgilio, F., Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. Mol. Biol. Cell 16 (2005), 3260–3272.
3. Adinolfi, E., Cirillo, M., Woltersdorf, R., Falzoni, S., Chiozzi, P., Pellegatti, P., Callegari, M.G., Sandonà, D., Markwardt, F., Schmalzing, G., Di Virgilio, F., Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor. FASEB J. 24 (2010), 3393–3404.
4. Adinolfi, E., Capece, M., Franceschini, A., Falzoni, S., Giuliani, A.L., Rotondo, A., Sarti, A.C., Bonora, M., Syberg, S., Corigliano, D., et al. Accelerated tumor progression in mice lacking the ATP receptor P2X7. Cancer Res. 75 (2015), 635–644.
5. Alberto, A.V., Faria, R.X., Couto, C.G., Ferreira, L.G., Souza, C.A., Teixeira, P.C., Fróes, M.M., Alves, L.A., Is pannexin the pore associated with the P2X7 receptor?. Naunyn Schmiedebergs Arch. Pharmacol. 386 (2013), 775–787.
6. Ali, S.R., Timmer, A.M., Bilgrami, S., Park, E.J., Eckmann, L., Nizet, V., Karin, M., Anthrax toxin induces macrophage death by p38 MAPK inhibition but leads to inflammasome activation via ATP leakage. Immunity 35 (2011), 34–44.
7. Alzola, E., Pérez-Etxebarria, A., Kabré, E., Fogarty, D.J., Métioui, M., Chaïb, N., Macarulla, J.M., Matute, C., Dehaye, J.P., Marino, A., Activation by P2X7 agonists of two phospholipases A2 (PLA2) in ductal cells of rat submandibular gland. Coupling of the calcium-independent PLA2 with kallikrein secretion. J. Biol. Chem. 273 (1998), 30208–30217.
8. Amaral, E.P., Ribeiro, S.C., Lanes, V.R., Almeida, F.M., de Andrade, M.R., Bomfim, C.C., Salles, E.M., Bortoluci, K.R., Coutinho-Silva, R., Hirata, M.H., et al. Pulmonary infection with hypervirulent Mycobacteria reveals a crucial role for the P2X7 receptor in aggressive forms of tuberculosis. PLoS Pathog., 10, 2014, e1004188.
9. Amoroso, F., Falzoni, S., Adinolfi, E., Ferrari, D., Di Virgilio, F., The P2X7 receptor is a key modulator of aerobic glycolysis. Cell Death Dis., 3, 2012, e370.
10. Amoroso, F., Capece, M., Rotondo, A., Cangelosi, D., Ferracin, M., Franceschini, A., Raffaghello, L., Pistoia, V., Varesio, L., Adinolfi, E., The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma. Oncogene 34 (2015), 5240–5251.
11. Arulkumaran, N., Unwin, R.J., Tam, F.W., A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin. Investig. Drugs 20 (2011), 897–915.
12. Atarashi, K., Nishimura, J., Shima, T., Umesaki, Y., Yamamoto, M., Onoue, M., Yagita, H., Ishii, N., Evans, R., Honda, K., Takeda, K., ATP drives lamina propria T(H)17 cell differentiation. Nature 455 (2008), 808–812.
13. Baconguis, I., Hattori, M., Gouaux, E., Unanticipated parallels in architecture and mechanism between ATP-gated P2X receptors and acid sensing ion channels. Curr. Opin. Struct. Biol. 23 (2013), 277–284.
14. Barberà-Cremades, M., Baroja-Mazo, A., Gomez, A.I., Machado, F., Di Virgilio, F., Pelegrín, P., P2X7 receptor-stimulation causes fever via PGE2 and IL-1β release. FASEB J. 26 (2012), 2951–2962.
15. Barberà-Cremades, M., Baroja-Mazo, A., Pelegrín, P., Purinergic signaling during macrophage differentiation results in M2 alternative activated macrophages. J. Leukoc. Biol. 99 (2016), 289–299.
16. Baricordi, O.R., Ferrari, D., Melchiorri, L., Chiozzi, P., Hanau, S., Chiari, E., Rubini, M., Di Virgilio, F., An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. Blood 87 (1996), 682–690.
17. Baricordi, O.R., Melchiorri, L., Adinolfi, E., Falzoni, S., Chiozzi, P., Buell, G., Di Virgilio, F., Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor. J. Biol. Chem. 274 (1999), 33206–33208.
18. Baroni, M., Pizzirani, C., Pinotti, M., Ferrari, D., Adinolfi, E., Calzavarini, S., Caruso, P., Bernardi, F., Di Virgilio, F., Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. FASEB J. 21 (2007), 1926–1933.
19. Bartlett, R., Stokes, L., Sluyter, R., The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease. Pharmacol. Rev. 66 (2014), 638–675.
20. Basso, A.M., Bratcher, N.A., Harris, R.R., Jarvis, M.F., Decker, M.W., Rueter, L.E., Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders. Behav. Brain Res. 198 (2009), 83–90.
21. + T-regulatory cell function and allograft survival. FASEB J. 29 (2015), 2315–2326.
22. Bianchi, G., Vuerich, M., Pellegatti, P., Marimpietri, D., Emionite, L., Marigo, I., Bronte, V., Di Virgilio, F., Pistoia, V., Raffaghello, L., ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment. Cell Death Dis., 5, 2014, e1135.
23. Bianco, F., Pravettoni, E., Colombo, A., Schenk, U., Möller, T., Matteoli, M., Verderio, C., Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. J. Immunol. 174 (2005), 7268–7277.
24. Bianco, F., Perrotta, C., Novellino, L., Francolini, M., Riganti, L., Menna, E., Saglietti, L., Schuchman, E.H., Furlan, R., Clementi, E., et al. Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J. 28 (2009), 1043–1054.
25. Bortner, C.D., Hughes, F.M. Jr., Cidlowski, J.A., A primary role for K+ and Na+ efflux in the activation of apoptosis. J. Biol. Chem. 272 (1997), 32436–32442.
26. Boué-Grabot, E., Archambault, V., Séguéla, P., A protein kinase C site highly conserved in P2X subunits controls the desensitization kinetics of P2X(2) ATP-gated channels. J. Biol. Chem. 275 (2000), 10190–10195.
27. Bradford, M.D., Soltoff, S.P., P2X7 receptors activate protein kinase D and p42/p44 mitogen-activated protein kinase (MAPK) downstream of protein kinase C. Biochem. J. 366 (2002), 745–755.
28. Browne, L.E., Compan, V., Bragg, L., North, R.A., P2X7 receptor channels allow direct permeation of nanometer-sized dyes. J. Neurosci. 33 (2013), 3557–3566.
29. Burnstock, G., Physiology and pathophysiology of purinergic neurotransmission. Physiol. Rev. 87 (2007), 659–797.
30. Burnstock, G., Verkhratsky, A., Evolutionary origins of the purinergic signalling system. Acta Physiol. (Oxf.) 195 (2009), 415–447.
31. Cabrini, G., Falzoni, S., Forchap, S.L., Pellegatti, P., Balboni, A., Agostini, P., Cuneo, A., Castoldi, G., Baricordi, O.R., Di Virgilio, F., A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. J. Immunol. 175 (2005), 82–89.
32. Casares, N., Pequignot, M.O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J. Exp. Med. 202 (2005), 1691–1701.
33. Cekic, C., Linden, J., Purinergic regulation of the immune system. Nat. Rev. Immunol. 16 (2016), 177–192.
34. Chataigneau, T., Lemoine, D., Grutter, T., Exploring the ATP-binding site of P2X receptors. Front. Cell. Neurosci., 7, 2013, 273.
35. Cheewatrakoolpong, B., Gilchrest, H., Anthes, J.C., Greenfeder, S., Identification and characterization of splice variants of the human P2X7 ATP channel. Biochem. Biophys. Res. Commun. 332 (2005), 17–27.
36. Chessell, I.P., Hatcher, J.P., Bountra, C., Michel, A.D., Hughes, J.P., Green, P., Egerton, J., Murfin, M., Richardson, J., Peck, W.L., et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114 (2005), 386–396.
37. Cockcroft, S., Gomperts, B.D., ATP induces nucleotide permeability in rat mast cells. Nature 279 (1979), 541–542.
38. Coddou, C., Yan, Z., Obsil, T., Huidobro-Toro, J.P., Stojilkovic, S.S., Activation and regulation of purinergic P2X receptor channels. Pharmacol. Rev. 63 (2011), 641–683.
39. Colegio, O.R., Chu, N.Q., Szabo, A.L., Chu, T., Rhebergen, A.M., Jairam, V., Cyrus, N., Brokowski, C.E., Eisenbarth, S.C., Phillips, G.M., et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513 (2014), 559–563.
40. Coull, J.A., Beggs, S., Boudreau, D., Boivin, D., Tsuda, M., Inoue, K., Gravel, C., Salter, M.W., De Koninck, Y., BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438 (2005), 1017–1021.
41. Coutinho-Silva, R., Ojcius, D.M., Role of extracellular nucleotides in the immune response against intracellular bacteria and protozoan parasites. Microbes Infect. 14 (2012), 1271–1277.
42. Coutinho-Silva, R., Stahl, L., Raymond, M.N., Jungas, T., Verbeke, P., Burnstock, G., Darville, T., Ojcius, D.M., Inhibition of chlamydial infectious activity due to P2X7R-dependent phospholipase D activation. Immunity 19 (2003), 403–412.
43. Csóka, B., Németh, Z.H., Törő, G., Idzko, M., Zech, A., Koscsó, B., Spolarics, Z., Antonioli, L., Cseri, K., Erdélyi, K., et al. Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing. FASEB J. 29 (2015), 3626–3637.
44. Dal Ben, D., Buccioni, M., Lambertucci, C., Marucci, G., Thomas, A., Volpini, R., Purinergic P2X receptors: structural models and analysis of ligand-target interaction. Eur. J. Med. Chem. 89 (2015), 561–580.
45. Dang, E.V., Barbi, J., Yang, H.Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.R., et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146 (2011), 772–784.
46. Danquah, W., Meyer-Schwesinger, C., Rissiek, B., Pinto, C., Serracant-Prat, A., Amadi, M., Iacenda, D., Knop, J.H., Hammel, A., Bergmann, P., et al. Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation. Sci. Transl. Med., 8, 2016, 366ra162.
47. De Marchi, E., Orioli, E., Dal Ben, D., Adinolfi, E., P2X7 receptor as a therapeutic target. Adv. Protein Chem. Struct. Biol. 104 (2016), 39–79.
48. Denlinger, L.C., Fisette, P.L., Sommer, J.A., Watters, J.J., Prabhu, U., Dubyak, G.R., Proctor, R.A., Bertics, P.J., Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J. Immunol. 167 (2001), 1871–1876.
49. Di Virgilio, F., The therapeutic potential of modifying inflammasomes and NOD-like receptors. Pharmacol. Rev. 65 (2013), 872–905.
50. Di Virgilio, F., Adinolfi, E., Extracellular purines, purinergic receptors and tumor growth. Oncogene 36 (2017), 293–303.
51. Di Virgilio, F., Meyer, B.C., Greenberg, S., Silverstein, S.C., Fc receptor-mediated phagocytosis occurs in macrophages at exceedingly low cytosolic Ca2+ levels. J. Cell Biol. 106 (1988), 657–666.
52. Di Virgilio, F., Bronte, V., Collavo, D., Zanovello, P., Responses of mouse lymphocytes to extracellular adenosine 5′-triphosphate (ATP). Lymphocytes with cytotoxic activity are resistant to the permeabilizing effects of ATP. J. Immunol. 143 (1989), 1955–1960.
53. Di Virgilio, F., Chiozzi, P., Falzoni, S., Ferrari, D., Sanz, J.M., Venketaraman, V., Baricordi, O.R., Cytolytic P2X purinoceptors. Cell Death Differ. 5 (1998), 191–199.
54. Dinarello, C.A., The IL-1 family and inflammatory diseases. Clin. Exp. Rheumatol. 20:5, Suppl 27 (2002), S1–S13.
55. Dubyak, G.R., P2X7 receptor regulation of non-classical secretion from immune effector cells. Cell. Microbiol. 14 (2012), 1697–1706.
56. el-Moatassim, C., Dubyak, G.R., A novel pathway for the activation of phospholipase D by P2z purinergic receptors in BAC1.2F5 macrophages. J. Biol. Chem. 267 (1992), 23664–23673.
57. Elssner, A., Duncan, M., Gavrilin, M., Wewers, M.D., A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J. Immunol. 172 (2004), 4987–4994.
58. Eser, A., Colombel, J.F., Rutgeerts, P., Vermeire, S., Vogelsang, H., Braddock, M., Persson, T., Reinisch, W., Safety and efficacy of an oral inhibitor of the purinergic receptor P2X7 in adult patients with moderately to severely active Crohn's disease: A randomized placebo-controlled, double-blind, phase IIa study. Inflamm. Bowel Dis. 21 (2015), 2247–2253.
59. Falzoni, S., Munerati, M., Ferrari, D., Spisani, S., Moretti, S., Di Virgilio, F., The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J. Clin. Invest. 95 (1995), 1207–1216.
60. Fan, Z.D., Zhang, Y.Y., Guo, Y.H., Huang, N., Ma, H.H., Huang, H., Yu, H.G., Involvement of P2X7 receptor signaling on regulating the differentiation of Th17 cells and type II collagen-induced arthritis in mice. Sci. Rep., 6, 2016, 35804.
61. Fantoni, E.R., Dal Ben, D., Falzoni, S., Di Virgilio, F., Lovestone, S., Gee, A., Design, synthesis and evaluation in an LPS rodent model of neuroinflammation of a novel (18)F-labelled PET tracer targeting P2X7. EJNMMI Res., 7, 2017, 31.
62. Feng, Y.H., Li, X., Wang, L., Zhou, L., Gorodeski, G.I., A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization. J. Biol. Chem. 281 (2006), 17228–17237.
63. Ferrari, D., Villalba, M., Chiozzi, P., Falzoni, S., Ricciardi-Castagnoli, P., Di Virgilio, F., Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J. Immunol. 156 (1996), 1531–1539.
64. Ferrari, D., Chiozzi, P., Falzoni, S., Dal Susino, M., Melchiorri, L., Baricordi, O.R., Di Virgilio, F., Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159 (1997), 1451–1458.
65. Ferrari, D., Los, M., Bauer, M.K., Vandenabeele, P., Wesselborg, S., Schulze-Osthoff, K., P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett. 447 (1999), 71–75.
66. Ferrari, D., La Sala, A., Chiozzi, P., Morelli, A., Falzoni, S., Girolomoni, G., Idzko, M., Dichmann, S., Norgauer, J., Di Virgilio, F., The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. FASEB J. 14 (2000), 2466–2476.
67. Ferrari, D., Pizzirani, C., Adinolfi, E., Forchap, S., Sitta, B., Turchet, L., Falzoni, S., Minelli, M., Baricordi, R., Di Virgilio, F., The antibiotic polymyxin B modulates P2X7 receptor function. J. Immunol. 173 (2004), 4652–4660.
68. Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R.M., Curti, A., Idzko, M., Panther, E., Di Virgilio, F., The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 176 (2006), 3877–3883.
69. Fowler, B.J., Gelfand, B.D., Kim, Y., Kerur, N., Tarallo, V., Hirano, Y., Amarnath, S., Fowler, D.H., Radwan, M., Young, M.T., et al. Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity. Science 346 (2014), 1000–1003.
70. Franceschini, A., Capece, M., Chiozzi, P., Falzoni, S., Sanz, J.M., Sarti, A.C., Bonora, M., Pinton, P., Di Virgilio, F., The P2X7 receptor directly interacts with the NLRP3 inflammasome scaffold protein. FASEB J. 29 (2015), 2450–2461.
71. Fuller, S.J., Stokes, L., Skarratt, K.K., Gu, B.J., Wiley, J.S., Genetics of the P2X7 receptor and human disease. Purinergic Signal. 5 (2009), 257–262.
72. Gaidt, M.M., Ebert, T.S., Chauhan, D., Schmidt, T., Schmid-Burgk, J.L., Rapino, F., Robertson, A.A., Cooper, M.A., Graf, T., Hornung, V., Human monocytes engage an alternative inflammasome pathway. Immunity 44 (2016), 833–846.
73. Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., Kroemer, G., Immunogenic cell death in cancer and infectious disease. Nat. Rev. Immunol. 17 (2017), 97–111.
74. Garcia-Marcos, M., Pochet, S., Marino, A., Dehaye, J.P., P2X7 and phospholipid signalling: the search of the “missing link” in epithelial cells. Cell. Signal. 18 (2006), 2098–2104.
75. Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat. Med. 15 (2009), 1170–1178.
76. Gilbert, S.M., Gidley Baird, A., Glazer, S., Barden, J.A., Glazer, A., Teh, L.C., King, J. (2017). A phase I clinical trial demonstrates that nfP2X7-targeted antibodies provide a novel, safe, and tolerable topical therapy for basal cell carcinoma. Published online February 2, 2017. http://dx.doi.org/10.1111/bjd.15364.
77. Gourine, A.V., Poputnikov, D.M., Zhernosek, N., Melenchuk, E.V., Gerstberger, R., Spyer, K.M., Gourine, V.N., P2 receptor blockade attenuates fever and cytokine responses induced by lipopolysaccharide in rats. Br. J. Pharmacol. 146 (2005), 139–145.
78. Graziano, F., Desdouits, M., Garzetti, L., Podini, P., Alfano, M., Rubartelli, A., Furlan, R., Benaroch, P., Poli, G., Extracellular ATP induces the rapid release of HIV-1 from virus containing compartments of human macrophages. Proc. Natl. Acad. Sci. USA 112 (2015), E3265–E3273.
79. Gu, B.J., Wiley, J.S., Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor. Blood 107 (2006), 4946–4953.
80. Gu, B., Bendall, L.J., Wiley, J.S., Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood 92 (1998), 946–951.
81. Gu, B.J., Zhang, W., Worthington, R.A., Sluyter, R., Dao-Ung, P., Petrou, S., Barden, J.A., Wiley, J.S., A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J. Biol. Chem. 276 (2001), 11135–11142.
82. Gu, B.J., Sluyter, R., Skarratt, K.K., Shemon, A.N., Dao-Ung, L.P., Fuller, S.J., Barden, J.A., Clarke, A.L., Petrou, S., Wiley, J.S., An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor. J. Biol. Chem. 279 (2004), 31287–31295.
83. Gunosewoyo, H., Kassiou, M., P2X purinergic receptor ligands: recently patented compounds. Expert Opin. Ther. Pat. 20 (2010), 625–646.
84. Harkat, M., Peverini, L., Cerdan, A.H., Dunning, K., Beudez, J., Martz, A., Calimet, N., Specht, A., Cecchini, M., Chataigneau, T., Grutter, T., On the permeation of large organic cations through the pore of ATP-gated P2X receptors. Proc. Natl. Acad. Sci. USA 114 (2017), E3786–E3795.
85. Hashimoto-Hill, S., Friesen, L., Kim, M., Kim, C.H., Contraction of intestinal effector T cells by retinoic acid-induced purinergic receptor P2X7. Mucosal Immunol. 10 (2017), 912–923.
86. Hattori, M., Gouaux, E., Molecular mechanism of ATP binding and ion channel activation in P2X receptors. Nature 485 (2012), 207–212.
87. He, Y., Franchi, L., Núñez, G., TLR agonists stimulate Nlrp3-dependent IL-1β production independently of the purinergic P2X7 receptor in dendritic cells and in vivo. J. Immunol. 190 (2013), 334–339.
88. He, Y., Zeng, M.Y., Yang, D., Motro, B., Núñez, G., NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530 (2016), 354–357.
89. Hirayama, Y., Ikeda-Matsuo, Y., Notomi, S., Enaida, H., Kinouchi, H., Koizumi, S., Astrocyte-mediated ischemic tolerance. J. Neurosci. 35 (2015), 3794–3805.
90. Hubert, S., Rissiek, B., Klages, K., Huehn, J., Sparwasser, T., Haag, F., Koch-Nolte, F., Boyer, O., Seman, M., Adriouch, S., Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway. J. Exp. Med. 207 (2010), 2561–2568.
91. Humphreys, B.D., Dubyak, G.R., Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-gamma in the human THP-1 monocytic cell line. J. Immunol. 157 (1996), 5627–5637.
92. Idzko, M., Ferrari, D., Eltzschig, H.K., Nucleotide signalling during inflammation. Nature 509 (2014), 310–317.
93. Jacobson, K.A., Müller, C.E., Medicinal chemistry of adenosine, P2Y and P2X receptors. Neuropharmacology 104 (2016), 31–49.
94. Jiang, L.H., Baldwin, J.M., Roger, S., Baldwin, S.A., Insights into the molecular mechanisms underlying mammalian P2X7 receptor functions and contributions in diseases, revealed by structural modeling and single nucleotide polymorphisms. Front. Pharmacol., 4, 2013, 55.
95. Jimenez-Mateos, E.M., Arribas-Blazquez, M., Sanz-Rodriguez, A., Concannon, C., Olivos-Ore, L.A., Reschke, C.R., Mooney, C.M., Mooney, C., Lugara, E., Morgan, J., et al. microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus. Sci. Rep., 5, 2015, 17486.
96. Jørgensen, N.R., Husted, L.B., Skarratt, K.K., Stokes, L., Tofteng, C.L., Kvist, T., Jensen, J.E., Eiken, P., Brixen, K., Fuller, S., et al. Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures. Eur. J. Hum. Genet. 20 (2012), 675–681.
97. Junger, W.G., Immune cell regulation by autocrine purinergic signalling. Nat. Rev. Immunol. 11 (2011), 201–212.
98. Kaczmarek-Hájek, K., Lörinczi, E., Hausmann, R., Nicke, A., Molecular and functional properties of P2X receptors–recent progress and persisting challenges. Purinergic Signal. 8 (2012), 375–417.
99. Karasawa, A., Kawate, T., Structural basis for subtype-specific inhibition of the P2X7 receptor. eLife, 5, 2016, e22153.
100. Karki, P., Seong, C., Kim, J.E., Hur, K., Shin, S.Y., Lee, J.S., Cho, B., Park, I.S., Intracellular K(+) inhibits apoptosis by suppressing the Apaf-1 apoptosome formation and subsequent downstream pathways but not cytochrome c release. Cell Death Differ. 14 (2007), 2068–2075.
101. Karmakar, M., Katsnelson, M.A., Dubyak, G.R., Pearlman, E., Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP. Nat. Commun., 7, 2016, 10555.
102. Kasuya, G., Fujiwara, Y., Takemoto, M., Dohmae, N., Nakada-Nakura, Y., Ishitani, R., Hattori, M., Nureki, O., Structural insights into divalent cation modulations of ATP-gated P2X receptor channels. Cell Rep. 14 (2016), 932–944.
103. Kataoka, A., Tozaki-Saitoh, H., Koga, Y., Tsuda, M., Inoue, K., Activation of P2X7 receptors induces CCL3 production in microglial cells through transcription factor NFAT. J. Neurochem. 108 (2009), 115–125.
104. Kawamura, H., Aswad, F., Minagawa, M., Govindarajan, S., Dennert, G., P2X7 receptors regulate NKT cells in autoimmune hepatitis. J. Immunol. 176 (2006), 2152–2160.
105. Kawate, T., Michel, J.C., Birdsong, W.T., Gouaux, E., Crystal structure of the ATP-gated P2X(4) ion channel in the closed state. Nature 460 (2009), 592–598.
106. Kayagaki, N., Stowe, I.B., Lee, B.L., O'Rourke, K., Anderson, K., Warming, S., Cuellar, T., Haley, B., Roose-Girma, M., Phung, Q.T., et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526 (2015), 666–671.
107. Kerur, N., Hirano, Y., Tarallo, V., Fowler, B.J., Bastos-Carvalho, A., Yasuma, T., Yasuma, R., Kim, Y., Hinton, D.R., Kirschning, C.J., et al. TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy. Invest. Ophthalmol. Vis. Sci. 54 (2013), 7395–7401.
108. Keystone, E.C., Wang, M.M., Layton, M., Hollis, S., McInnes, I.B., D1520C00001 Study Team. Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine. Ann. Rheum. Dis. 71 (2012), 1630–1635.
109. Killeen, M.E., Ferris, L., Kupetsky, E.A., Falo, L. Jr., Mathers, A.R., Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis. J. Immunol. 190 (2013), 4324–4336.
110. Kim, M., Jiang, L.H., Wilson, H.L., North, R.A., Surprenant, A., Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J. 20 (2001), 6347–6358.
111. Kroemer, G., Galluzzi, L., Kepp, O., Zitvogel, L., Immunogenic cell death in cancer therapy. Annu. Rev. Immunol. 31 (2013), 51–72.
112. Kurashima, Y., Amiya, T., Nochi, T., Fujisawa, K., Haraguchi, T., Iba, H., Tsutsui, H., Sato, S., Nakajima, S., Iijima, H., et al. Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors. Nat. Commun., 3, 2012, 1034.
113. Laliberte, R.E., Perregaux, D.G., McNiff, P., Gabel, C.A., Human monocyte ATP-induced IL-1 beta posttranslational processing is a dynamic process dependent on in vitro growth conditions. J. Leukoc. Biol. 62 (1997), 227–239.
114. Lammas, D.A., Stober, C., Harvey, C.J., Kendrick, N., Panchalingam, S., Kumararatne, D.S., ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity 7 (1997), 433–444.
115. Ledderose, C., Bao, Y., Ledderose, S., Woehrle, T., Heinisch, M., Yip, L., Zhang, J., Robson, S.C., Shapiro, N.I., Junger, W.G., Mitochondrial dysfunction, depleted purinergic signaling, and defective T cell vigilance and immune defense. J. Infect. Dis. 213 (2016), 456–464.
116. Ledderose, C., Woehrle, T., Ledderose, S., Strasser, K., Seist, R., Bao, Y., Zhang, J., Junger, W.G., Cutting off the power: inhibition of leukemia cell growth by pausing basal ATP release and P2X receptor signaling?. Purinergic Signal. 12 (2016), 439–451.
117. Lenertz, L.Y., Wang, Z., Guadarrama, A., Hill, L.M., Gavala, M.L., Bertics, P.J., Mutation of putative N-linked glycosylation sites on the human nucleotide receptor P2X7 reveals a key residue important for receptor function. Biochemistry 49 (2010), 4611–4619.
118. Liang, X., Samways, D.S., Wolf, K., Bowles, E.A., Richards, J.P., Bruno, J., Dutertre, S., DiPaolo, R.J., Egan, T.M., Quantifying Ca2+ current and permeability in ATP-gated P2X7 receptors. J. Biol. Chem. 290 (2015), 7930–7942.
119. Lin, J., Krishnaraj, R., Kemp, R.G., Exogenous ATP enhances calcium influx in intact thymocytes. J. Immunol. 135 (1985), 3403–3410.
120. Lopez-Castejon, G., Brough, D., Understanding the mechanism of IL-1β secretion. Cytokine Growth Factor Rev. 22 (2011), 189–195.
121. MacKenzie, A., Wilson, H.L., Kiss-Toth, E., Dower, S.K., North, R.A., Surprenant, A., Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15 (2001), 825–835.
122. Mackenzie, A.B., Young, M.T., Adinolfi, E., Surprenant, A., Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors. J. Biol. Chem. 280 (2005), 33968–33976.
123. Maître, B., Magnenat, S., Heim, V., Ravanat, C., Evans, R.J., de la Salle, H., Gachet, C., Hechler, B., The P2X1 receptor is required for neutrophil extravasation during lipopolysaccharide-induced lethal endotoxemia in mice. J. Immunol. 194 (2015), 739–749.
124. Mansoor, S.E., Lü, W., Oosterheert, W., Shekhar, M., Tajkhorshid, E., Gouaux, E., X-ray structures define human P2X(3) receptor gating cycle and antagonist action. Nature 538 (2016), 66–71.
125. Martinon, F., Burns, K., Tschopp, J., The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10 (2002), 417–426.
126. Mascanfroni, I.D., Yeste, A., Vieira, S.M., Burns, E.J., Patel, B., Sloma, I., Wu, Y., Mayo, L., Ben-Hamo, R., Efroni, S., et al. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nat. Immunol. 14 (2013), 1054–1063.
127. Mascanfroni, I.D., Takenaka, M.C., Yeste, A., Patel, B., Wu, Y., Kenison, J.E., Siddiqui, S., Basso, A.S., Otterbein, L.E., Pardoll, D.M., et al. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α. Nat. Med. 21 (2015), 638–646.
128. Masin, M., Young, C., Lim, K., Barnes, S.J., Xu, X.J., Marschall, V., Brutkowski, W., Mooney, E.R., Gorecki, D.C., Murrell-Lagnado, R., Expression, assembly and function of novel C-terminal truncated variants of the mouse P2X7 receptor: re-evaluation of P2X7 knockouts. Br. J. Pharmacol. 165 (2012), 978–993.
129. 7 receptor in infectious diseases. PLoS Pathog., 7, 2011, e1002212.
130. Minkiewicz, J., de Rivero Vaccari, J.P., Keane, R.W., Human astrocytes express a novel NLRP2 inflammasome. Glia 61 (2013), 1113–1121.
131. Monção-Ribeiro, L.C., Faffe, D.S., Santana, P.T., Vieira, F.S., da Graça, C.L., Marques-da-Silva, C., Machado, M.N., Caruso-Neves, C., Zin, W.A., Borojevic, R., et al. P2X7 receptor modulates inflammatory and functional pulmonary changes induced by silica. PLoS ONE, 9, 2014, e110185.
132. Moore, S.F., MacKenzie, A.B., Murine macrophage P2X7 receptors support rapid prothrombotic responses. Cell. Signal. 19 (2007), 855–866.
133. Mortimer, L., Moreau, F., Cornick, S., Chadee, K., The NLRP3 inflammasome is a pathogen sensor for invasive Entamoeba histolytica via activation of α5β1 integrin at the macrophage-amebae intercellular Junction. PLoS Pathog., 11, 2015, e1004887.
134. Munerati, M., Cortesi, R., Ferrari, D., Di Virgilio, F., Nastruzzi, C., Macrophages loaded with doxorubicin by ATP-mediated permeabilization: potential carriers for antitumor therapy. Biochim. Biophys. Acta 1224 (1994), 269–276.
135. + efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38 (2013), 1142–1153.
136. Murgia, M., Hanau, S., Pizzo, P., Rippa, M., Di Virgilio, F., Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. J. Biol. Chem. 268 (1993), 8199–8203.
137. Nicke, A., Kuan, Y.H., Masin, M., Rettinger, J., Marquez-Klaka, B., Bender, O., Górecki, D.C., Murrell-Lagnado, R.D., Soto, F., A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice. J. Biol. Chem. 284 (2009), 25813–25822.
138. Niemi, K., Teirilä, L., Lappalainen, J., Rajamäki, K., Baumann, M.H., Öörni, K., Wolff, H., Kovanen, P.T., Matikainen, S., Eklund, K.K., Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway. J. Immunol. 186 (2011), 6119–6128.
139. Norde, W.J., Overes, I.M., Maas, F., Fredrix, H., Vos, J.C., Kester, M.G., van der Voort, R., Jedema, I., Falkenburg, J.H., Schattenberg, A.V., et al. Myeloid leukemic progenitor cells can be specifically targeted by minor histocompatibility antigen LRH-1-reactive cytotoxic T cells. Blood 113 (2009), 2312–2323.
140. North, R.A., Molecular physiology of P2X receptors. Physiol. Rev. 82 (2002), 1013–1067.
141. Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G.M., Apetoh, L., Perfettini, J.L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat. Med. 13 (2007), 54–61.
142. Omosun, Y., McKeithen, D., Ryans, K., Kibakaya, C., Blas-Machado, U., Li, D., Singh, R., Inoue, K., Xiong, Z.G., Eko, F., et al. Interleukin-10 modulates antigen presentation by dendritic cells through regulation of NLRP3 inflammasome assembly during Chlamydia infection. Infect. Immun. 83 (2015), 4662–4672.
143. Ory, D., Celen, S., Gijsbers, R., Van Den Haute, C., Postnov, A., Koole, M., Vandeputte, C., Andrés, J.I., Alcazar, J., De Angelis, M., et al. Preclinical evaluation of a P2X7 receptor-selective radiotracer: PET studies in a rat model with local overexpression of the human P2X7 receptor and in nonhuman primates. J. Nucl. Med. 57 (2016), 1436–1441.
144. Pandolfi, J.B., Ferraro, A.A., Sananez, I., Gancedo, M.C., Baz, P., Billordo, L.A., Fainboim, L., Arruvito, L., ATP-induced inflammation drives tissue-resident Th17 cells in metabolically unhealthy obesity. J. Immunol. 196 (2016), 3287–3296.
145. Panenka, W., Jijon, H., Herx, L.M., Armstrong, J.N., Feighan, D., Wei, T., Yong, V.W., Ransohoff, R.M., MacVicar, B.A., P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J. Neurosci. 21 (2001), 7135–7142.
146. Panupinthu, N., Rogers, J.T., Zhao, L., Solano-Flores, L.P., Possmayer, F., Sims, S.M., Dixon, S.J., P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis. J. Cell Biol. 181 (2008), 859–871.
147. Park, J.H., Kim, Y.C., P2X7 receptor antagonists: a patent review (2010-2015). Expert Opin. Ther. Pat. 27 (2017), 257–267.
148. Park, E., Na, H.S., Song, Y.R., Shin, S.Y., Kim, Y.M., Chung, J., Activation of NLRP3 and AIM2 inflammasomes by Porphyromonas gingivalis infection. Infect. Immun. 82 (2014), 112–123.
149. Pellegatti, P., Falzoni, S., Pinton, P., Rizzuto, R., Di Virgilio, F., A novel recombinant plasma membrane-targeted luciferase reveals a new pathway for ATP secretion. Mol. Biol. Cell 16 (2005), 3659–3665.
150. Pellegatti, P., Raffaghello, L., Bianchi, G., Piccardi, F., Pistoia, V., Di Virgilio, F., Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS ONE, 3, 2008, e2599.
151. Perregaux, D., Gabel, C.A., Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J. Biol. Chem. 269 (1994), 15195–15203.
152. Perregaux, D.G., Gabel, C.A., Human monocyte stimulus-coupled IL-1beta posttranslational processing: modulation via monovalent cations. Am. J. Physiol. 275 (1998), C1538–C1547.
153. Perregaux, D.G., McNiff, P., Laliberte, R., Conklyn, M., Gabel, C.A., ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood. J. Immunol. 165 (2000), 4615–4623.
154. Piccioli, P., Rubartelli, A., The secretion of IL-1β and options for release. Semin. Immunol. 25 (2013), 425–429.
155. Pippel, A., Stolz, M., Woltersdorf, R., Kless, A., Schmalzing, G., Markwardt, F., Localization of the gate and selectivity filter of the full-length P2X7 receptor. Proc. Natl. Acad. Sci. USA 114 (2017), E2156–E2165.
156. Pizzirani, C., Ferrari, D., Chiozzi, P., Adinolfi, E., Sandonà, D., Savaglio, E., Di Virgilio, F., Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. Blood 109 (2007), 3856–3864.
157. Proietti, M., Cornacchione, V., Rezzonico Jost, T., Romagnani, A., Faliti, C.E., Perruzza, L., Rigoni, R., Radaelli, E., Caprioli, F., Preziuso, S., et al. ATP-gated ionotropic P2X7 receptor controls follicular T helper cell numbers in Peyer's patches to promote host-microbiota mutualism. Immunity 41 (2014), 789–801.
158. Qu, Y., Franchi, L., Nunez, G., Dubyak, G.R., Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J. Immunol. 179 (2007), 1913–1925.
159. Resta, V., Novelli, E., Vozzi, G., Scarpa, C., Caleo, M., Ahluwalia, A., Solini, A., Santini, E., Parisi, V., Di Virgilio, F., Galli-Resta, L., Acute retinal ganglion cell injury caused by intraocular pressure spikes is mediated by endogenous extracellular ATP. Eur. J. Neurosci. 25 (2007), 2741–2754.
160. Rissiek, B., Danquah, W., Haag, F., Koch-Nolte, F., Technical Advance: a new cell preparation strategy that greatly improves the yield of vital and functional Tregs and NKT cells. J. Leukoc. Biol. 95 (2014), 543–549.
161. Rizzo, R., Ferrari, D., Melchiorri, L., Stignani, M., Gulinelli, S., Baricordi, O.R., Di Virgilio, F., Extracellular ATP acting at the P2X7 receptor inhibits secretion of soluble HLA-G from human monocytes. J. Immunol. 183 (2009), 4302–4311.
162. Robinson, L.E., Murrell-Lagnado, R.D., The trafficking and targeting of P2X receptors. Front. Cell. Neurosci., 7, 2013, 233.
163. Roger, S., Jelassi, B., Couillin, I., Pelegrin, P., Besson, P., Jiang, L.H., Understanding the roles of the P2X7 receptor in solid tumour progression and therapeutic perspectives. Biochim. Biophys. Acta 1848:10 Pt B (2015), 2584–2602.
164. Sanz, J.M., Chiozzi, P., Ferrari, D., Colaianna, M., Idzko, M., Falzoni, S., Fellin, R., Trabace, L., Di Virgilio, F., Activation of microglia by amyloid beta requires P2X7 receptor expression. J. Immunol. 182 (2009), 4378–4385.
165. Schenk, U., Frascoli, M., Proietti, M., Geffers, R., Traggiai, E., Buer, J., Ricordi, C., Westendorf, A.M., Grassi, F., ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci. Signal., 4, 2011, ra12.
166. Seman, M., Adriouch, S., Scheuplein, F., Krebs, C., Freese, D., Glowacki, G., Deterre, P., Haag, F., Koch-Nolte, F., NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity 19 (2003), 571–582.
167. Shenker, B.J., Ojcius, D.M., Walker, L.P., Zekavat, A., Scuron, M.D., Boesze-Battaglia, K., Aggregatibacter actinomycetemcomitans cytolethal distending toxin activates the NLRP3 inflammasome in human macrophages, leading to the release of proinflammatory cytokines. Infect. Immun. 83 (2015), 1487–1496.
168. Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., Shao, F., Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526 (2015), 660–665.
169. Shieh, C.H., Heinrich, A., Serchov, T., van Calker, D., Biber, K., P2X7-dependent, but differentially regulated release of IL-6, CCL2, and TNF-α in cultured mouse microglia. Glia 62 (2014), 592–607.
170. Shiratori, M., Tozaki-Saitoh, H., Yoshitake, M., Tsuda, M., Inoue, K., P2X7 receptor activation induces CXCL2 production in microglia through NFAT and PKC/MAPK pathways. J. Neurochem. 114 (2010), 810–819.
171. Sim, J.A., Young, M.T., Sung, H.Y., North, R.A., Surprenant, A., Reanalysis of P2X7 receptor expression in rodent brain. J. Neurosci. 24 (2004), 6307–6314.
172. Sinadinos, A., Young, C.N., Al-Khalidi, R., Teti, A., Kalinski, P., Mohamad, S., Floriot, L., Henry, T., Tozzi, G., Jiang, T., et al. P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy. PLoS Med., 12, 2015, e1001888.
173. Sluyter, R., Stokes, L., Significance of P2X7 receptor variants to human health and disease. Recent Pat. DNA Gene Seq. 5 (2011), 41–54.
174. Solini, A., Chiozzi, P., Morelli, A., Fellin, R., Di Virgilio, F., Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. J. Cell Sci. 112 (1999), 297–305.
175. Solle, M., Labasi, J., Perregaux, D.G., Stam, E., Petrushova, N., Koller, B.H., Griffiths, R.J., Gabel, C.A., Altered cytokine production in mice lacking P2X(7) receptors. J. Biol. Chem. 276 (2001), 125–132.
176. Steinberg, T.H., Silverstein, S.C., Extracellular ATP4- promotes cation fluxes in the J774 mouse macrophage cell line. J. Biol. Chem. 262 (1987), 3118–3122.
177. Stock, T.C., Bloom, B.J., Wei, N., Ishaq, S., Park, W., Wang, X., Gupta, P., Mebus, C.A., Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate. J. Rheumatol. 39 (2012), 720–727.
178. Stokes, L., Fuller, S.J., Sluyter, R., Skarratt, K.K., Gu, B.J., Wiley, J.S., Two haplotypes of the P2X(7) receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1beta secretion. FASEB J. 24 (2010), 2916–2927.
179. Sun, C., Chu, J., Singh, S., Salter, R.D., Identification and characterization of a novel variant of the human P2X(7) receptor resulting in gain of function. Purinergic Signal. 6 (2010), 31–45.
180. Sung, S.S., Young, J.D., Origlio, A.M., Heiple, J.M., Kaback, H.R., Silverstein, S.C., Extracellular ATP perturbs transmembrane ion fluxes, elevates cytosolic [Ca2+], and inhibits phagocytosis in mouse macrophages. J. Biol. Chem. 260 (1985), 13442–13449.
181. Surprenant, A., Rassendren, F., Kawashima, E., North, R.A., Buell, G., The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272 (1996), 735–738.
182. Syberg, S., Petersen, S., Beck Jensen, J.E., Gartland, A., Teilmann, J., Chessell, I., Steinberg, T.H., Schwarz, P., Jørgensen, N.R., Genetic background strongly influences the bone phenotype of P2X7 receptor knockout mice. J. Osteoporos., 2012, 2012, 391097.
183. Taylor, S.R., Gonzalez-Begne, M., Dewhurst, S., Chimini, G., Higgins, C.F., Melvin, J.E., Elliott, J.I., Sequential shrinkage and swelling underlie P2X7-stimulated lymphocyte phosphatidylserine exposure and death. J. Immunol. 180 (2008), 300–308.
184. Taylor, S.R., Gonzalez-Begne, M., Sojka, D.K., Richardson, J.C., Sheardown, S.A., Harrison, S.M., Pusey, C.D., Tam, F.W., Elliott, J.I., Lymphocytes from P2X7-deficient mice exhibit enhanced P2X7 responses. J. Leukoc. Biol. 85 (2009), 978–986.
185. Territo, P.R., Meyer, J.A., Peters, J.S., Riley, A.A., McCarthy, B.P., Gao, M., Wang, M., Green, M.A., Zheng, Q.H., Hutchins, G.D., Characterization of (11)C-GSK1482160 for targeting the P2X7 receptor as a biomarker for neuroinflammation. J. Nucl. Med. 58 (2017), 458–465.
186. Tomasinsig, L., Pizzirani, C., Skerlavaj, B., Pellegatti, P., Gulinelli, S., Tossi, A., Di Virgilio, F., Zanetti, M., The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner. J. Biol. Chem. 283 (2008), 30471–30481.
187. Tsuda, M., Shigemoto-Mogami, Y., Koizumi, S., Mizokoshi, A., Kohsaka, S., Salter, M.W., Inoue, K., P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424 (2003), 778–783.
188. Vergani, A., Tezza, S., D'Addio, F., Fotino, C., Liu, K., Niewczas, M., Bassi, R., Molano, R.D., Kleffel, S., Petrelli, A., et al. Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7. Circulation 127 (2013), 463–475.
189. Verkhratsky, A., Burnstock, G., Biology of purinergic signalling: its ancient evolutionary roots, its omnipresence and its multiple functional significance. BioEssays 36 (2014), 697–705.
190. Walev, I., Reske, K., Palmer, M., Valeva, A., Bhakdi, S., Potassium-inhibited processing of IL-1 beta in human monocytes. EMBO J. 14 (1995), 1607–1614.
191. Wallach, D., Kang, T.B., Dillon, C.P., Green, D.R., Programmed necrosis in inflammation: Toward identification of the effector molecules. Science, 352, 2016, aaf2154.
192. Wei, W., Ryu, J.K., Choi, H.B., McLarnon, J.G., Expression and function of the P2X(7) receptor in rat C6 glioma cells. Cancer Lett. 260 (2008), 79–87.
193. Wiley, J.S., Sluyter, R., Gu, B.J., Stokes, L., Fuller, S.J., The human P2X7 receptor and its role in innate immunity. Tissue Antigens 78 (2011), 321–332.
194. Wilhelm, K., Ganesan, J., Müller, T., Dürr, C., Grimm, M., Beilhack, A., Krempl, C.D., Sorichter, S., Gerlach, U.V., Jüttner, E., et al. Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R. Nat. Med. 16 (2010), 1434–1438.
195. Woehrle, T., Yip, L., Elkhal, A., Sumi, Y., Chen, Y., Yao, Y., Insel, P.A., Junger, W.G., Pannexin-1 hemichannel-mediated ATP release together with P2X1 and P2X4 receptors regulate T-cell activation at the immune synapse. Blood 116 (2010), 3475–3484.
196. Yang, D., He, Y., Muñoz-Planillo, R., Liu, Q., Núñez, G., Caspase-11 requires the pannexin-1 channel and the purinergic P2X7 pore to mediate pyroptosis and endotoxic shock. Immunity 43 (2015), 923–932.
197. Zanovello, P., Bronte, V., Rosato, A., Pizzo, P., Di Virgilio, F., Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation. J. Immunol. 145 (1990), 1545–1550.